2[1]David L.Overview of role of ERCP in the management of diseases of the biliary tract and the pancreas.Gastrointestinal Endoscopy 2002; 56:613-617
3[2]ASGE guidelines for clinical application.The role of ERCP in diseases of the biliary tract and pancreas.American Society for Gastrointestinal Endoscopy.Gastrointest Endosc 1999; 50:915-920
4[3]Rey JR,Axon A,Budzynska A,Kruse A,Nowak A.Guidelines of the European Society of Gastrointestinal Endoscopy (E.S.G.E.) antibiotic prophylaxis for gastrointestinal endoscopy.European Society of Gastrointestinal Endoscopy.Endoscopy 1998; 30:318-324
5[4]Bilbao MK,Dotter CT,Lee TG,Katon RM.Complications of endoscopic retrograde cholangiopancreatography (ERCP).A study of 10,000 cases.Gastroenterology 1976; 70:314-320
6[5]Sung JJ,Lyon DJ,Suen R,Chung SC,Co AL,Cheng AF,Leung JW,Li AK.Intravenous ciprofloxacin as treatment for patients with acute suppurative cholangitis:a randomized,controlled clinical trial.J Antimicrob Chemother 1995; 35:855-864
7[6]van den Hazel SJ,Speelman P,Tytgat GN,Dankert J,van Leeuwen DJ.Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis.Clin Infect Dis 1994; 19:279-286
8[7]Mehal WZ,Culshaw KD,Tillotson GS,Chapman RW.Antibiotic prophylaxis for ERCP:a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.Eur J Gastroenterol Hepatol 1995; 7:841-845
9[8]Niederau C,Pohlmann U,Lubke H,Thomas L.Prophylactic antibiotic treatment in therapeutic or complicated diagnostic ERCP:results of a randomized controlled clinical study.Gastrointest Endosc 1994; 40:533-537
